⌘K

Login Start Free

Home/Filings/4/A/0001096481-11-000012

4/A//SEC Filing

Hunter William L 4/A

Accession 0001096481-11-000012

CIK 0001096481other

View on SEC.gov Company Profile

Filed

May 16, 8:00 PM ET

Accepted

May 17, 5:37 PM ET

Size

40.5 KB

Accession

0001096481-11-000012

Insider Transaction Report

Form 4/AAmended

Period: 2011-05-12

ANGIOTECH PHARMACEUTICALS INCANPI

Hunter William L

DirectorPresident & CEO

Transactions

Other
Stock Option w/Tandem SAR
2011-05-12−500,000→ 800,000 total
Exercise: $0.21From: 2009-01-01Exp: 2013-12-07→ Common Stock (500,000 underlying)
Other
Common Stock
2011-05-12−435,356→ 5,478,335 total(indirect: By Spouse)
Other
Common Stock
2011-05-12−375,000→ 5,103,335 total(indirect: By Spouse)
Other
Common Stock
2011-05-12−89,692→ 821,499 total(indirect: By Spouse)
Other
Common Stock
2011-05-12−567,595→ 1,101,124 total(indirect: By Spouse)
Other
Common Stock
2011-05-12−33,000→ 911,191 total(indirect: By Spouse)
Other
Common Stock
2011-05-12−476,813→ 220,338 total(indirect: By Spouse)
Other
Awards
2011-05-12−400,000→ 1,650,000 total
Exercise: $13.47From: 2002-12-01Exp: 2012-12-17→ Common Stock (400,000 underlying)
Other
Stock Option w/Tandem SAR
2011-05-12−300,000→ 0 total
Exercise: $1.09From: 2010-04-01Exp: 2015-03-07→ Common Stock (300,000 underlying)
Other
Common Stock
2011-05-12−102,000→ 5,001,335 total(indirect: By Spouse)
Other
Common Stock
2011-05-12−3,332,616→ 1,668,719 total(indirect: By Spouse)
Other
Common Stock
2011-05-12−156,933→ 944,191 total(indirect: By Spouse)
Other
Common Stock
2011-05-12−40,848→ 780,651 total(indirect: By Spouse)
Other
Common Stock
2011-05-12−53,000→ 727,651 total(indirect: By Spouse)
Other
Common Stock
2011-05-12−30,500→ 697,151 total(indirect: By Spouse)
Other
Common Stock
2011-05-12−47,000→ 15,600 total(indirect: By Spouse)
Other
Common Stock
2011-05-12−15,600→ 0 total(indirect: By Spouse)
Other
Common Stock
2011-05-12−157,738→ 62,600 total(indirect: By Spouse)
Other
Awards
2011-05-12−350,000→ 1,300,000 total
Exercise: $8.90From: 2007-03-01Exp: 2012-02-04→ Common Stock (350,000 underlying)
Other
Stock Option w/Tandem SAR
2011-05-12−500,000→ 300,000 total
Exercise: $0.38From: 2009-04-01Exp: 2014-03-09→ Common Stock (500,000 underlying)

Footnotes (2)

[F1]Effective on May 12, 2011, all of the Company's existing common shares and options to acquire common shares were cancelled without any payment or consideration therefor, in connection with the implementation of a plan of compromise or arrangement under the Companies' Creditors Arrangement Act (Canada).
[F2]Price is in Canadian dollars.

Documents

1 file

4
primary_doc.xml
PRIMARY DOCUMENT

Issuer

ANGIOTECH PHARMACEUTICALS INC

CIK 0001096481

Entity typeother

Related Parties

1

filerCIK 0001432062

Filing Metadata

Form type: 4/A
Filed: May 16, 8:00 PM ET
Accepted: May 17, 5:37 PM ET
Size: 40.5 KB

View on SEC.gov